Serentil

   
Google
 
Web NewDrugInformation.com

Serentil


Drug - Serentil
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Mesoridazine Besylate
Multiple ingredients are in alphabetical order.

Strength - EQ 100MG BASE
The potency of the active ingredient(s), Mesoridazine Besylate. May repeat for multiple part products.

Applicant - NOVARTIS
The firm name holding legal responsibility for Serentil. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 016774
The FDA assigned number to Serentil. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Serentil. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Serentil was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Serentil. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Serentil is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novartis Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Serentil.

Serentil